DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB18894
| null |
Visugromab
|
2556646-63-8
|
NX3NW9MM9W
|
Visugromab
| null |
DB18895
| null |
Verzistobart
|
2649466-18-0
|
KAC8QY6TMN
|
INCAGN 02390 | INCAGN-02390 | INCAGN02390 | Verzistobart
| null |
DB18896
| null |
Vamikibart
|
2744320-12-3
|
KP04MH1JTT
|
Vamikibart
| null |
DB18897
| null |
BI-187004
|
1303515-32-3
|
280XKM6Z2K
|
1h-indeno(2,1-b)pyridine-6-carbonitrile, 1-(1h-benzimidazol-6-ylcarbonyl)-2,3,4,4a,9,9a-hexahydro-, (4ar,9as)-
|
VVZNCSHIBODHMZ-UZLBHIALSA-N
|
DB18898
| null |
Pyrifazimine
|
1353734-12-9
|
TY9R7N6MS5
|
2-PHENAZINAMINE, 3,5-DIHYDRO-3-((4-METHOXYCYCLOHEXYL)IMINO)-N-(2-METHOXY-3-PYRIDINYL)-5-(4-(TRIFLUOROMETHOXY)PHENYL)-
|
GUSGYHIQYWRCQO-UHFFFAOYSA-N
|
DB18899
| null |
JNJ-39758979
|
1046447-90-8
|
5RV7T5BNMG
|
2-PYRIMIDINAMINE, 4-((3R)-3-AMINO-1-PYRROLIDINYL)-6-(1-METHYLETHYL)-
|
COOGVHJHSCBOQT-MRVPVSSYSA-N
|
DB18900
| null |
ASTX-029
|
2095719-92-7
|
14FDK6ISC9
|
2H-ISOINDOLE-2-ACETAMIDE, 6-(5-CHLORO-2-((TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-PYRIMIDINYL)-N-((1S)-1-(3-FLUORO-5-METHOXYPHENYL)-2-HYDROXYETHYL)-1,3-DIHYDRO-.ALPHA.-METHYL-1-OXO-, (.ALPHA.R)-
|
BVRGQPJKSKKGIH-PUAOIOHZSA-N
|
DB18901
| null |
INCB-086550
|
2230911-59-6
|
T8B91S15VF
|
3-PYRROLIDINECARBOXYLIC ACID, 1-((7-CYANO-2-(3'-((3-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-1,7-NAPHTHYRIDIN-8-YL)AMINO)-2,2'-DIMETHYL(1,1'-BIPHENYL)-3-YL)-5-BENZOXAZOLYL)METHYL)-, (3R)-
|
QARLNMDDSQMINK-BVRKHOPBSA-N
|
DB18902
| null |
BMS-770767
|
1875067-34-7
|
45T8YQ8DDW
|
4-(8-(2-CHLOROPHENOXY)(1,2,4)TRIAZOLO(4,3-A)PYRIDIN-3-YL)BICYCLO(2.2.1)HEPTAN-1-OL | BICYCLO(2.2.1)HEPTAN-1-OL, 4-(8-(2-CHLOROPHENOXY)-1,2,4-TRIAZOLO(4,3-A)PYRIDIN-3-YL)-
|
HNXGIFYHJKEXNA-UHFFFAOYSA-N
|
DB18903
| null |
ORC-13661
|
1979935-33-5
|
KJ7XLN1TIR
|
(1R,8S)-4-{[(4-chlorophenyl)carbamoyl]amino}-11-methyl-5-thia-11-azatricyclo[6.2.1.0<sup>2,6</sup>]undeca-2-(6),3-diene-3-carboxamide | (4R,6S)-2-[[[(4-Chlorophenyl)amino]carbonyl]amino]-4,5,6,7-tetrahydro-5-methyl-4,6-ethanothieno[3,2-c]pyridine-3-carboxamide | 4,6-Ethanothieno[3,2-c]pyridine-3-carboxamide, 2-[[[(4-chlorophenyl)amino]carbonyl]amino]-4,5,6,7-tetrahydro-5-methyl-, (4R,6S)-
|
DAHGONXBHYVOPI-NWDGAFQWSA-N
|
DB18904
| null |
MK-8777
|
1026791-61-6
|
0H1IDR8Z4F
|
5H,7H-PYRIDO(3,2-F)PYRROLO(2,1-C)(1,4)OXAZEPIN-5-ONE, 8,9,9A,10-TETRAHYDRO-, (9AS)-
|
FIKUEZUFASUKAH-QMMMGPOBSA-N
|
DB18905
| null |
Abiraterone decanoate
|
2486052-18-8
|
U6XMS339F5
| null |
XPCSGTPPHYORKJ-YHXMLEJGSA-N
|
DB18906
| null |
MG-4101
| null |
WX2ZW10GHO
|
ALLOGENEIC NATURAL KILLER CELL LINE MG4101
| null |
DB18907
| null |
ANC-501
|
1370444-22-6
|
575OB1CKN0
|
3-(3-Chlorophenyl)-1,5-dihydro-N-(1-methylethyl)-1-[4-[2-(4-morpholinyl)ethyl]phenyl]-5-oxo-4H-1,2,4-triazole-4-acetamide
|
YCLGGNJZGIFVKX-UHFFFAOYSA-N
|
DB18908
| null |
ANEB-001
|
791848-71-0
|
4RNU8C6XXW
|
1-AZETIDINECARBOXAMIDE, 3-((R)-(4-CHLOROPHENYL)(2-(TRIFLUOROMETHYL)PHENYL)METHOXY)-N-(1,1-DIMETHYLETHYL)- | 3-((R)-(4-CHLOROPHENYL)(2-(TRIFLUOROMETHYL)PHENYL)METHOXY)-N-(1,1-DIMETHYLETHYL)-1-AZETIDINECARBOXAMIDE
|
BNLYOVHLLDBOFZ-LJQANCHMSA-N
|
DB18909
| null |
Apelin
|
372170-33-7
|
7P5ZL6T59Y
| null | null |
DB18910
| null |
ADL-5859
|
850305-06-5
|
FA554TW3UP
|
BENZAMIDE, N,N-DIETHYL-4-(5-HYDROXYSPIRO(2H-1-BENZOPYRAN-2,4'-PIPERIDIN)-4-YL)-
|
OPIKUXLJQFYMSC-UHFFFAOYSA-N
|
DB18911
| null |
TBI-223
|
2071265-08-0
|
B4RS1V5YSP
|
CARBAMIC ACID, N-(((5S)-3-(3-FLUORO-4-(2-OXA-6-AZASPIRO(3.3)HEPT-6-YL)PHENYL)-2-OXO-5-OXAZOLIDINYL)METHYL)-, METHYL ESTER
|
ZNBRXLSWXJKKLJ-LBPRGKRZSA-N
|
DB18912
| null |
Carbapenem
|
78854-41-8
|
GL970841YS
|
(5r)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid | (5r)-carbapenem | (5r)-carbapenem-3-carboxylic acid | 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 7-oxo-, (5r)- | Antibiotic tan 458 | Carbapenem, (5r)-
|
BSIMZHVOQZIAOY-SCSAIBSYSA-N
|
DB18913
| null |
Cardiopet
|
855927-17-2
|
FDG79C95XB
|
(18f fcpha) | (18f)-fcpha | 2-((1s,2r)-2-(5-(fluoro-18f)tridecyl)cyclopropyl)acetic acid | Cyclopropaneacetic acid, 2-(5-(fluoro-18f)tridecyl)-, (1r,2s)-rel- | Trans-9(rs)-18f-fluoro-3,4(rs,rs)-methyleneheptadecanoic acid
|
DDTRZLZETKPBPQ-YWWFHXEUSA-N
|
DB18914
| null |
Tifcemalimab
|
2236068-83-8
|
D40H7X1YZ0
|
Icatolimab | Immunoglobulin g4, anti-(human b and t lymphocyte attenuator (btla)) (human-mus musculus monoclonal js004 .gamma.4-chain), disulfide with human-mus musculus monoclonal js004 .kappa.-chain, dimer
| null |
DB18915
| null |
Cefetamet pivoxil
|
65243-33-6
|
F6XA85N260
|
5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r-(6.alpha.,7.beta.(z)))- | Cefatamet pivoxil | Cefetamet pivaloyloxymethyl ester | Cefetamet pivoxyl
|
DASYMCLQENWCJG-XUKDPADISA-N
|
DB18916
| null |
Teropavimab
|
2417213-72-8
|
6MQW0DZ370
|
Immunoglobulin g1 (434-leucine,440-serine), anti-(human immunodeficiency virus 1 envelope protein gp120env) (human monoclonal 8c11-62a12 .gamma.1-chain), disulfide with human monoclonal 8c11-62a12 .kappa.-chain, dimer
| null |
DB18917
| null |
Edecesertib
|
2408839-73-4
|
3NUJ7N1277
|
3-Pyridinecarboxamide, 4-[[(1R)-1-cyanoethyl]amino]-6-(3-cyanopyrrolo[1,2-b]pyridazin-7-yl)-N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]- | 4-{[(1R)-1-cyanoethyl]amino}-6-(3-cyanopyrrolo[1,2- b]pyridazin-7-yl)-N-[(2R)-2-fluoro-3-hydroxy-3- methylbutyl]pyridine-3-carboxamide | Edecesertib
|
HORBHQPSWJRDSV-ZUOKHONESA-N
|
DB18918
| null |
Elzovantinib
|
2271119-26-5
|
TTY12Q00LY
|
1,15-Etheno-1H-pyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecine-12-carbonitrile, 3-amino-14-ethyl-11-fluoro-4,5,6,7,13,14-hexahydro-7-methyl-4-oxo-, (7S)- | Elzovantinib
|
UUDPUQDMSHQSKH-NSHDSACASA-N
|
DB18919
| null |
Sibeprenlimab
|
2382896-07-1
|
GHX28QZ7DD
|
Immunoglobulin g2, anti-(human proliferation-inducing ligand protein) (human monoclonal vis649 .gamma.2-chain), disulfide with human monoclonal vis649 .kappa.-chain, dimer
| null |
DB18920
| null |
Semzuvolimab
|
2409099-32-5
|
4180O0RM6K
|
DB4C7 mAb | Mab db4c7
| null |
DB18921
| null |
Lacripep
|
2243095-21-6
|
0OZ3G9FQP9
| null | null |
DB18922
| null |
Rulonilimab
|
2417124-95-7
|
KQA6N2NT4Z
|
F520 | Immunoglobulin g1 (251-glutamine,298-alanine,429-leucine), anti-(human programmed cell death protein 1) (human-mus musculus monoclonal f520 .gamma.1-chain), disulfide with human-mus musculus monoclonal f520 .kappa.-chain, dimer
| null |
DB18923
| null |
Ertumaxomab
|
509077-99-0
|
L5L45YGP1O
|
Anti-cd3 x anti-her-2-neu bispecific monoclonal antibody
| null |
DB18924
| null |
Fazpilodemab
|
2517935-02-1
|
VVE4UQ5M6P
|
Anti-fgfr1/klb mab | Bfkb-8488a (bispecific antibody designed to mimic the metabolic hormone fgf21). | immunoglobulin G1-kappa, anti-[Homo sapiens KLB (klotho beta, b-Klotho)] and anti-[Homo sapiens FGFR1 (fibroblast growth factor receptor 1, FLT2, KAL2)], monoclonal antibody, bispecific; gamma1 heavy chain anti-KLB (1-450) [VH (Homo sapiens IGHV3-66*01 ( | mmunoglobulin G1 [369-serine,371-alanine,410-valine], anti-(human β-Klotho protein) (human monoclonal HKLB4206 γ1-chain), disulfide with monoclonal HKLB4206 κ-chain, (229→225'),(232→228')-bis(disulfide) with immunoglobulin G1 [365-tryptophan] ant
| null |
DB18925
| null |
Sunvozertinib
|
2370013-12-8
|
L1Q2K5JYO8
|
N-{5-[(4-{[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino}pyrimidin-2-yl)amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl}prop-2-enamide
|
BTMKEDDEMKKSEF-QGZVFWFLSA-N
|
DB18926
| null |
Frexalimab
|
2515463-86-0
|
WO7SFK0ENJ
|
Immunoglobulin G1 (272-arginine,325-alanine), anti-(human CD40 ligand) (human-mus musculus monoclonal SAR441344 gamma1-chain), disulfide with human-mus musculus monoclonal SAR441344 kappa-chain, dimer
| null |
DB18927
| null |
Suzetrigine
|
2649467-58-1
|
LOG73M21H5
|
4-[[[(2R,3S,4S,5R)-3-(3,4-Difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]-2-pyridinecarboxamide
|
XSQUJFKRXZMOKA-PAFIKIDNSA-N
|
DB18928
| null |
Gefurulimab
|
2456407-94-4
|
6PWU78BV6C
|
IMMUNOGLOBULIN, BISPECIFIC, ANTI-(HUMAN SERUM ALBUMIN) (HUMAN-LAMA GLAMA MONOCLONAL ALXN1720 SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (SYNTHETIC 15 AMINO-ACID) FUSION PROTEIN WITH ANTI-(HUMAN COMPLEMENT C5) (HUMAN-LAMA GLAMA MONOCLO
| null |
DB18929
| null |
Zilebesiran
|
2380166-33-4
|
E422BH4BRK
|
(2S,4R)-1-{1-[(2-acetamido-2-deoxy-β-D-galactopyranosyl)oxy]-16,16-bis({3-[(3-{5-[(2- acetamido-2-deoxy-β-D-galactopyranosyl)oxy]pentanamido}propyl)amino]-3-oxopropoxy}methyl)-5,11,18-trioxo-14-oxa-6,10,17- triazanonacosan-29-oyl}-4-hydroxypyrrolidin-
| null |
DB18930
| null |
Ichorcumab
|
2589583-20-8
|
UW0H6X9FSQ
| null | null |
DB18931
| null |
Ivonescimab
|
2428381-53-5
|
Y0O332CU66
|
IMMUNOGLOBULIN G1 (240-ALANINE,241-ALANINE), ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A) (HUMAN-MUS MUSCULUS MONOCLONAL AK112 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGS)4 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN PROGRAMMED CELL
| null |
DB18932
| null |
Acasunlimab
|
2253937-12-9
|
H52ITZ9X9D
|
acasunlimab [INN]
| null |
DB18933
| null |
Izuralimab
|
2329669-80-7
|
9D2R4T39AY
|
IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS ICOS (INDUCIBLE T-CELL COSTIMULATORY, ACTIVATION-INDUCIBLE LYMPHOCYTE IMMUNOMEDIATORY MOLECULE, AILIM, CD278)) AND ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), M | IMMUNOGLOBULIN, ANTI-(HUMAN PROGRAMMED CELL DEATH 1) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB23104 SINGLE-CHAIN VARIABLE FRAGMENT VL-LINKER-VH) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT), (260->234'),(263->237')-
| null |
DB18934
| null |
Barzolvolimab
|
2438203-51-9
|
4B77GX0NA3
|
Immunoglobulin G1 [233-alanine,234-glutamine,251-tyrosine,253-threonine,255-glutamic acid,321-glutamine,de-C-terminal-lysine], anti-(human receptor tyrosine kinase KIT extracellular domain) (human-Mus musculus monoclonal CDX-0159 γ1-chain), disulfide wi
| null |
DB18935
| null |
Burfiralimab
|
2460809-80-5
|
82WF2WG4MP
|
burfiralimab [INN] | IMMUNOGLOBULIN G4, ANTI-(HUMAN VIMENTIN) (HUMAN-MUS MUSCULUS .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS .KAPPA.-CHAIN, DIMER
| null |
DB18936
| null |
Licaminlimab
|
1688648-13-6
|
D5ZJ707VIR
|
immunoglobulin scFv, anti-[Homo sapiens TNF (tumor necrosis factor, TNFSF2, DIF, TNF-alpha)], humanized monoclonal antibody single chain; IG scFv humanized single chain (V-KAPPA-VH) (1-254) [V-KAPPA (Homo sapiens IGKV1-5*03 (79.2%) -(IGHD) -IGKJ2*02 (77. | Immunoglobulin, anti-(human tumor necrosis factor α)(human-Oryctolagus cuniculus monoclonal ESBA1622 scFv fragment)
| null |
DB18937
| null |
Tarcocimab tedromer
|
2411896-53-0
|
7HW5CX6OD5
|
Immunoglobulin G1 [240-alanine,241-alanine,243-alanine,449-cysteine], anti-(human vascular endothelial growth factor A) (human-Mus musculus monoclonal OG1950 g1-chain), disulfide with human-Mus musculus monoclonal OG1950 k-chain, (232®232'),(235®235')-
| null |
DB18938
| null |
Pulocimab
|
2428381-49-9
|
FDL8DA4XV4
|
Immunoglobulin g1, anti-(human vascular endothelial growth factor receptor 2) (human monoclonal ak109 .gamma.1-chain), disulfide with human monoclonal ak109 .kappa.-chain, dimer
| null |
DB18939
| null |
Livmoniplimab
|
2412004-88-5
|
42SH7JCD82
|
Immunoglobulin g4 (234-proline), anti-(human protein garp-transforming growth factor .beta.1 complex) (human monoclonal abbv-151 .gamma.4-chain), disulfide with human monoclonal abbv-151 .kappa.-chain, dimer
| null |
DB18940
| null |
Lonigutamab
|
2362015-67-4
|
56GN9PT35D
|
Immunoglobulin g1 (de-c-terminal-lysine), anti-(human insulin-like growth factor i receptor) (human-mus musculus monoclonal hz208f2-4 .gamma.1-chain), disulfide with human-mus musculus monoclonal hz208f2-4 .kappa.-chain, dimer | Immunoglobulin g1-kappa, anti-(homo sapiens igf1r (insulin like growth factor 1 receptor, igf1-r, igf-1r, cd221)), humanized monoclonal antibody
| null |
DB18941
| null |
Posdinemab
|
2517973-04-3
|
6HG8JYS9D6
|
Immunoglobulin G1, anti-(human phosphorylated tau protein) (human-Mus musculus monoclonal JNJ-63733657 γ1-chain), disulfide with human-Mus musculus monoclonal JNJ-63733657 κ-chain, dimer
| null |
DB18942
| null |
Lorigerlimab
|
2416595-46-3
|
JM802R57SA
|
IMMUNOGLOBULIN, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS CLONE MG13.78 .KAPPA.-CHAIN V-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GGGSGGGG) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEI | MMUNOGLOBULIN G4 SCFV-H-CH2-CH3_SCFV, ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD1, PD-1, CD279)) AND ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)), CHIMERIC, HOMO SAPIENS AND HUMANIZED MONOCLONAL ANTIBODY, TET
| null |
DB18943
| null |
Ponsegromab
|
2368950-15-4
|
GXA6PF0254
|
Immunoglobulin g1 (237-alanine,238-alanine,240-alanine), anti-(human growth differentiation factor 15) (human-mus musculus monoclonal pf-06946860 .gamma.1-chain), disulfide with human-mus musculus monoclonal pf-06946860 .kappa.-chain, dimer | PF-06946860
| null |
DB18944
| null |
Plamotamab
|
2138442-31-4
|
5ENX424FNF
|
Anti-cd20/cd3 monoclonal antibody xmab13676
| null |
DB18945
| null |
Mapatumumab
|
658052-09-6
|
WZ1025JPGR
|
Immunoglobulin g1, anti-(human cytokine receptor dr4 (death receceptor 4)) (human monoclonal trm-1 heavy chain), disulfide with human monoclonal trm-1 .lambda.-chain, dimer | Immunoglobulin g1, anti-(human cytokine receptor dr4 (death receceptor 4)) (human monoclonal trm-1 heavy chain), disulphide with human monoclonal trm-1 .lambda.-chain, dimer | Immunoglobulin g1, anti-(human cytokine receptor dr4 (death receptor 4)) (human monoclonal trm-1 heavy chain), disulfide with human monoclonal trm-1 .lambda.-chain, dimer | Immunoglobulin g1, anti-(human trail-r1) (human monoclonal trm-1 heavy chain), disulfide with human monoclonal trm-1 .lambda.-chain, dimer | Mab human (igg1) anti o00220 (tr10a_human) (hgs1012) | Trail-r 1mab | TRAIL-R1 mAb
| null |
DB18946
| null |
Nurulimab
|
2168561-20-2
|
894KSI08XK
|
Anti-ctla4 mab (biocad)
| null |
DB18947
| null |
Ociperlimab
|
2342597-93-5
|
7JNY4KV3NK
|
Immunoglobulin g1-kappa, anti-(homo sapiens tigit (t-cell immunoreceptor with ig domain and itim, v-set ig member 9, vsig9, v-set and transmembrane member 3, vstm3)), humanized monoclonal antibody (ociperlimab) | Immunoglobulin g1, anti-(human receptor tigit) (human-mus musculus monoclonal bgb-a1217 .gamma.1-chain), disulfide with human-mus musculus monoclonal bgb-a1217 .kappa.-chain, dimer
| null |
DB18948
| null |
Petosemtamab
|
2213450-26-9
|
Z6Z6IVE7W4
| null | null |
DB18949
| null |
Ongericimab
|
2145096-91-7
|
X126G5DZ36
|
Immunoglobulin g4-kappa, anti-(homo sapienspcsk9 (proprotein convertase subtilisin/kexin type 9, neural apoptosis-regulated convertase 1, narc1, narc-1, proprotein convertase 9, pc9)), humanized monoclonal antibody | Immunoglobulin g4, anti-(neural apoptosis-regulated convertase 1) (human monoclonal js002 .gamma.4-chain), disulfide with human monoclonal js002 .kappa.-chain, dimer
| null |
DB18950
| null |
Caricotamide
|
64881-21-6
|
MC09H30MFS
|
1-(2-amino-2-oxoethyl)-1,4-dihydropyridine-3-carboxamide
|
WEJRSYKFMCUCRQ-UHFFFAOYSA-N
|
DB18951
| null |
Cedirogant
|
2055496-11-0
|
X6466M4LVP
|
(1-(2,4-dichloro-3-((7-chloro-5-(trifluoromethyl)-1hindol-1-yl)methyl)benzoyl)piperidin-4-yl)acetic acid | 4-piperidineacetic acid, 1-(2,4-dichloro-3-((7-chloro-5-(trifluoromethyl)-1h-indol-1-yl)methyl)benzoyl)-
|
MNEOHCYSHVKLIC-UHFFFAOYSA-N
|
DB18952
| null |
Beludavimab
|
2423016-74-2
|
FM2MK5954W
|
IMMUNOGLOBULIN G1 (246-ALANINE,340-LEUCINE,342-GLUTAMIC ACID,438-LEUCINE,444-SERINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL VIR-7832 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOC
| null |
DB18953
| null |
Cemdomespib
|
1450642-92-8
|
T78QNE8JSI
|
Acetamide, n-(2-(5-((6-deoxy-5-c-methyl-4-o-methyl-.alpha.-l-lyxo-hexopyranosyl)oxy)-3'-fluoro(1,1'-biphenyl)-2-yl)ethyl)-
|
PDBWOHBMJQOBHL-WBADGQHESA-N
|
DB18954
| null |
TAK-071
|
1820812-16-5
|
59XC9G796Y
|
4-fluoro-2-((3s, 4s)-4-hydroxytetrahydro-2h-pyran-3-yl)-5-methyl-6-(4(1h-pyrazol-1-yl)benzyl)-2, 3-dihydro-1h-isoindol-1-one
|
WFSARWQASFQZMG-VXKWHMMOSA-N
|
DB18955
| null |
Sunobinop
|
1126793-40-5
|
I1X86U5474
|
2-quinoxalinecarboxylic acid, 4-((3-endo)-9-(3-exo)-bicyclo(3.3.1)non-3-yl-9-azabicyclo(3.3.1)non-3-yl)-3,4-dihydro-3-oxo- | 4-((1r,1'r,3r,3'r,5s,5's)-9'-aza(3,9'- bi(bicyclo(3.3.1)nonan))-3'-yl)-3-oxo-3,4- dihydroquinoxaline-2-carboxylic acid
|
COTYYZPYDJKKIS-VDRZXAFZSA-N
|
DB18956
| null |
Clesacostat
|
1370448-25-1
|
752DF9PPPI
|
4-(6-methoxy-4-(7-oxo-1-(propan-2-yl)-1,4,6,7-tetrahydrospiro(indazole-5,4'- piperidine)-1'-carbonyl)pyridin-2-yl)benzoic acid | Benzoic acid, 4-(6-methoxy-4-((1,4,6,7-tetrahydro-1-(1-methylethyl)-7-oxospiro(5h-indazole-5,4'-piperidin)-1'-yl)carbonyl)-2-pyridinyl)-
|
LXZMHBHEXAELHH-UHFFFAOYSA-N
|
DB18957
| null |
Lorundrostat
|
1820940-17-7
|
KA8W5LDS6Z
|
1-Piperazineacetamide, N-[trans-4-(acetylamino)cyclohexyl]-4-[5-(4-methylphenyl)-1,2,4-triazin-3-yl]- | Lorundrostat | N-(trans-4-acetamidocyclohexyl)-2-{4-[5-(4-methylphenyl)-1,2,4-triazin-3-yl]piperazin-1-yl}acetamide
|
YHGVDZULVMINCJ-MEMLXQNLSA-N
|
DB18958
| null |
CVN-424
|
2254706-21-1
|
XO01711URG
|
ETHANONE, 1-(2-(4-(2,4-DIFLUOROPHENOXY)-1-PIPERIDINYL)-7,8-DIHYDRO-3-(((3R)-TETRAHYDRO-3-FURANYL)AMINO)PYRIDO(3,4-B)PYRAZIN-6(5H)-YL)-
|
HSWVJQBEXRKOBZ-QGZVFWFLSA-N
|
DB18959
| null |
Methylcantharidimide
|
76970-78-0
|
62T9S2Y75E
|
4,7-EPOXY-1H-ISOINDOLE-1,3(2H)-DIONE, HEXAHYDRO-2,3A,7A-TRIMETHYL-, (3AR,4S,7R,7AS)-REL- | N-methylcantharidimide
|
WUQNOBSCYAIJIH-FIPCFZRWSA-N
|
DB18960
| null |
Dalosirvat
|
1360540-81-3
|
QX6T87A52I
|
1-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-phenyl-butane-1,4-dione | 1-(2,3-dihydro-benzo(1,4)dioxin-6-yl)-4-phenyl-butane-1,4-dione | 1,4-butanedione, 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-phenyl-
|
AOCDRSSVFUCURK-UHFFFAOYSA-N
|
DB18961
| null |
Minzasolmin
|
1802518-92-8
|
3N0435TG2D
|
Minzasolmin
|
GDFWCSZNQVAQGR-GOSISDBHSA-N
|
DB18962
| null |
Danicamtiv
|
1970972-74-7
|
7B2CS922HI
|
1-piperidinecarboxamide, 4-((1r)-1-((3-(difluoromethyl)-1-methyl-1h-pyrazol-4-yl)sulfonyl)-1-fluoroethyl)-n-3-isoxazolyl- | 4-((1r)-1-((3-(difluoromethyl)-1-methyl-1h-pyrazol-4-yl)sulfonyl)-1-fluoroethyl)-n-(1,2-oxazol-3-yl)piperidine-1-carboxamide
|
NREKKBAMVWQRES-MRXNPFEDSA-N
|
DB18963
| null |
Mitiperstat
|
1933460-19-5
|
S6GYK3X4QQ
|
1-({2-[(1R)-1-aminoethyl]-4-chlorophenyl}methyl)-2-sulfanylidene-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-one | 4H-Pyrrolo[3,2-d]pyrimidin-4-one, 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-1,2,3,5-tetrahydro-2-thioxo- | Mitiperstat
|
BHKKSKOHRFHHIN-MRVPVSSYSA-N
|
DB18964
| null |
Orforglipron
|
2212020-52-3
|
7ZW40D021M
|
1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dim | 3-[(1S,2S)-1-({2-(4-fluoro-3,5-dimethylphenyl)-3-({3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl]-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}carbonyl)-5-[(4S)-2,2-dimethyloxan-4-yl]-1H-indol-1-yl}-2-methylcyc | Orforglipron
|
USUWIEBBBWHKNI-KHIFEHGGSA-N
|
DB18965
| null |
Daphnetin
|
486-35-1
|
XC84571RD2
|
2h-1-benzopyran-2-one, 7,8-dihydroxy- | 7,8-dihydroxy-2h-1-benzopyran-2-one | 7,8-dihydroxycoumarin
|
ATEFPOUAMCWAQS-UHFFFAOYSA-N
|
DB18966
| null |
Darigabat
|
1614245-70-3
|
O9BP19HZ3Q
|
7-ethyl-4-(4'-(ethylsulfonyl)-6-fluoro-2'-methoxybiphenyl-3-yl)-7h-imidazo(4,5-c)-pyridazine | 7h-imidazo(4,5-c)pyridazine, 7-ethyl-4-(4'-(ethylsulfonyl)-6-fluoro-2'-methoxy(1,1'-biphenyl)-3-yl)-
|
PTTQXDBPTFOCMT-UHFFFAOYSA-N
|
DB18967
| null |
Ebvaciclib
|
2185857-97-8
|
3B512HJD65
|
6-(difluoromethyl)-8-((1r,2r)-2-hydroxy-2-methylcyclopentyl)-2-((1- (methylsulfonyl)piperidin-4-yl) amino)pyrido(2,3-d)pyrimidin-7(8h)-one | Pyrido(2,3-d)pyrimidin-7(8h)-one, 6-(difluoromethyl)-8-((1r,2r)-2-hydroxy-2-methylcyclopentyl)-2-((1-(methylsulfonyl)-4-piperidinyl)amino)-
|
QIEKHLDZKRQLLN-FOIQADDNSA-N
|
DB18968
| null |
Elinzanetant
|
929046-33-3
|
NZW2BOW35N
|
2-(3,5-bis(trifluoromethyl)phenyl)-n-(4-(4-fluoro-2-methylphenyl)-6-((7s,9as)-7-(hydroxymethyl)hexahydropyrazino(2,1-c)(1,4)oxazin-8(1h)-yl)-3-pyridinyl)-n,2-dimethylpropanamide | Benzamide, 3-(5-methyl-2-tbenzeneacetamide, n-(4-(4-fluoro-2-methylphenyl)-6-((7s,9as)-hexahydro-7-(hydroxymethyl)pyrazino(2,1-c)(1,4)oxazin-8(1h)-yl)-3-pyridinyl)-n,.alpha.,.alpha.-trimethyl-3,5-bis(trifluoromethyl)-
|
DWRIJNIPBUFCQS-DQEYMECFSA-N
|
DB18969
| null |
Elzasonan
|
361343-19-3
|
933PJL964R
|
(2z)-4-(3,4-dichlorphenyl)-2-(2-(4-methylpiperazin-1-yl)benzylidene)thiomorpholin-3-one | 3-thiomorpholinone, 4-(3,4-dichlorphenyl)-2-((2-(4-methyl-1-piperazinyl) phenyl)methylene)-, (2z)-
|
LHYMPSWMHXUWSK-STZFKDTASA-N
|
DB18970
| null |
Enavogliflozin
|
1415472-28-4
|
Z5MR2Y1IJJ
|
(1s)-1,5-anhydro-1-c-(7-chloro-6-((4-cyclopropylphenyl)methyl)-2,3-dihydro-4-benzofuranyl)-d-glucitol | D-glucitol, 1,5-anhydro-1-c-(7-chloro-6-((4-cyclopropylphenyl)methyl)-2,3-dihydro-4-benzofuranyl)-, (1s)-
|
KORCWPOBTZTAFI-YVTYUBGGSA-N
|
DB18971
| null |
Palazestrant
|
2092925-89-6
|
VU35KM56Q4
|
(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1-{4-[(1-propylazetidin-3- yl)oxy]phenyl}-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole | 1H-Pyrido[3,4-b]indole, 2-(2-fluoro-2-methylpropyl)-2,3,4,9-tetrahydro-3-methyl-1-[4-[(1-propyl-3-azetidinyl)oxy]phenyl]-, (1R,3R)- | Palazestrant
|
LBSFUBLFDCAEKV-XHCCPWGMSA-N
|
DB18972
| null |
Pimicotinib
| null |
HV1XI8HST2
|
1-Pyrrolidinecarboxamide, 3,3-dimethyl-N-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-2-oxo- | 3,3-Dimethyl-N-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-2-oxo-1-pyrrolidinecarboxamide | Pimicotinib
|
NXFPMDWYDKHFMM-UHFFFAOYSA-N
|
DB18973
| null |
Epaminurad
|
1198153-15-9
|
0YP1ME85GH
|
(3,5-dibromo-4-hydroxyphenyl)(2,3-dihydro-4h-pyrido(4,3-b)-1,4-oxazin-4-yl)methanone | Methanone, (3,5-dibromo-4-hydroxyphenyl)(2,3-dihydro-4h-pyrido(4,3-b)-1,4-oxazin-4-yl)-
|
ZMVGQIIOXCGAFV-UHFFFAOYSA-N
|
DB18974
| null |
Pirmitegravir
|
2245231-10-9
|
3XX9YW65ZA
|
(αS)-4-(4-Chlorophenyl)-α-(1,1-dimethylethoxy)-2,3,6-trimethyl-1-[(1-methyl-1H-pyrazol-4-yl)methyl]-1H-pyrrolo[2,3-b]pyridine-5-acetic acid | 1H-Pyrrolo[2,3-b]pyridine-5-acetic acid, 4-(4-chlorophenyl)-α-(1,1-dimethylethoxy)-2,3,6-trimethyl-1-[(1-methyl-1H-pyrazol-4-yl)methyl]-, (αS)- | Pirmitegravir
|
GNRDGAWRAIJOSU-DEOSSOPVSA-N
|
DB18975
| null |
Pomotrelvir
|
2713437-86-4
|
6XHD59349R
|
1H-Indole-2-carboxamide, 7-chloro-N-[(1S)-2-[[(1S)-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]amino]-1-(cyclopropylmethyl)-2-oxoethyl]- | 7-chloro-N-[(2S)-1-({(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl}amino)-3- cyclopropyl-1-oxopropan-2-yl]-1H-indole-2-carboxamide | Pomotrelvir
|
BNMFQWUHWYJTRI-BQFCYCMXSA-N
|
DB18976
| null |
Veligrotug
|
2728655-31-8
|
Z9U2SS9ZC8
|
Anti-cd122 monoclonal antibody ave1642 | Anti-igf-1r monoclonal antibody ave1642 | Immunoglobulin G1-kappa, anti-[Homo sapiens IGF1R (insulin-like growth factor 1 receptor, IGF1-R, IGF-1R, CD221)], chimeric monoclonal antibody (gamma1 heavy chain chimeric (1-454) [VH (Mus musculus IGHV1S81*02 (91.8%) -(IGHD) -IGHJ1*01 (93.8%), CDR-IMGT | Immunoglobulin G1, anti-(human insulin-like growth factor I receptor) (human-Mus musculus monoclonal VRDN-001 γ1-chain), disulfide with human-Mus musculus monoclonal VRDN-001 κ-chain, dimer
| null |
DB18977
| null |
Veverimer
|
2099678-27-8
|
10VSMQY402
|
1,3-propanediamine, n1,n3-di-2-propen-1-yl-, polymer with 1,2-dichloroethane and 2-propen-1-amine | N1,n3-bis(prop-2-en-1-yl)propan-1,3-diamine copolymer with 1,2-dichloroethane and prop-2-en-1-amine
| null |
DB18978
| null |
Vilamakitug
|
2458202-06-5
|
3562YZ5W3H
|
Immunoglobulin g4, anti-(human interleukin 1.alpha.) (human monoclonal xb2001 .gamma.4-chain), disulfide with human monoclonal xb2001 .kappa.-chain, dimer
| null |
DB18979
| null |
Relmacabtagene autoleucel
| null |
K5CXA4X5U8
|
AUTOLOGOUS CD4+ AND CD8+ T CELLS, ENRICHED FROM PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) TRANSDUCED WITH A NONREPLICATIVE SELF-INACTIVATING (SIN) LENTIVIRAL VECTOR ENCODING A CHIMERIC ANTIGEN RECEPTOR (CAR) CONSISTING OF THE HUMAN CD19-SPECIFIC SCFV | Carteyva | relma-cel | Relmacabtagene autoleucel
| null |
DB18980
| null |
Rezatapopt
|
2636846-41-6
|
5W59S33KC9
|
4-[[3-[4-[[(3S,4R)-3-Fluoro-1-methyl-4-piperidinyl]amino]-1-(2,2,2-trifluoroethyl)-1H-indol-2-yl]-2-propyn-1-yl]amino]-3-methoxy-N-methylbenzamide | Benzamide, 4-[[3-[4-[[(3S,4R)-3-fluoro-1-methyl-4-piperidinyl]amino]-1-(2,2,2-trifluoroethyl)-1H-indol-2-yl]-2-propyn-1-yl]amino]-3-methoxy-N-methyl- | Rezatapopt
|
NKRKBSQLUPEVCZ-JTHBVZDNSA-N
|
DB18981
| null |
Rifasutenizol
|
1001314-13-1
|
2G83RZK9U6
|
Rifasutenizol
|
GVNMWVKTEANXFY-RRKJDJKOSA-N
|
DB18982
| null |
Saruparib
|
2589531-76-8
|
16MZ1V3RBT
|
2-Pyridinecarboxamide, 5-[4-[(7-ethyl-5,6-dihydro-6-oxo-1,5-naphthyridin-3-yl)methyl]-1-piperazinyl]-N-methyl- | 5-{4-[(7-ethyl-5,6-dihydro-6-oxo-1,5-naphthyridin-3- yl)methyl]piperazin-1-yl}-N-methylpyridine-2- carboxamide | Saruparib
|
WQAVGRAETZEADU-UHFFFAOYSA-N
|
DB18983
| null |
Sevasemten
|
2417395-15-2
|
JT5OYR0WUK
|
2-[(5-fluoropyridin-3-yl)methyl]-6-[2-(2,2,2- trifluoroethoxy)pyrimidin-5-yl]pyridazin-3(2H)-one | Sevasemten
|
XFPJKQRXBAFXNK-UHFFFAOYSA-N
|
DB18984
| null |
Sudapyridine
|
1859978-72-5
|
7X86XPE5TG
|
3-Pyridineethanol, 5-(4-chlorophenyl)-α-[2-(dimethylamino)ethyl]-2-methoxy-α-1-naphthalenyl-β-phenyl-, (αS,βR)- | αS,βR)-5-(4-Chlorophenyl)-α-[2-(dimethylamino)ethyl]-2-methoxy-α-1-naphthalenyl-β-phenyl-3-pyridineethanol
|
MMUCHWPQRGEHDV-ZFEZZJPFSA-N
|
DB18985
| null |
Troplasminogen alfa
|
931101-84-7
|
M6PBS85QD0
| null | null |
DB18986
| null |
Tobevibart
|
2645440-65-7
|
PL93ZHC4L3
|
Immunoglobulin G1 [238-alanine,332-leucine,334-glutamic acid,430-leucine,436-serine], anti-(hepatitis B virus surface antigen) (human monoclonal VIR-3434 γ1-chain), disulfide with human monoclonal VIR-3434 λ-chain, dimer | Tobevibart
| null |
DB18987
| null |
Tobemstomig
|
2648839-43-2
|
93NRF4S9HR
|
Tobemstomig
| null |
DB18988
| null |
Tegileridine
|
2095345-66-5
|
YFJS8L4TGU
|
Tegileridine
|
YUMLNLMFBWBKSK-OHSXHVKISA-N
|
DB18989
| null |
Survodutide
|
2805997-46-8
|
2ALA66NS64
|
Survodutide
| null |
DB18990
| null |
Stapokibart
|
2734715-10-5
|
L2REN9TU2D
|
Immunoglobulin G4 [227-proline], anti-(human interleukin 4 receptor subunit α) (human-Mus musculus monoclonal CM310 γ4-chain), disulfide with human-Mus musculus monoclonal CM310 κ-chain, dimer | Stapokibart
| null |
DB18991
| null |
Rilvegostomig
|
2640305-01-5
|
YSL2GUT2Q8
|
Rilvegostomig
| null |
DB18992
| null |
Rezpegaldesleukin
|
2641686-76-0
|
VGR86P26ER
|
Rezpegaldesleukin
| null |
DB18993
| null |
Retatrutide
|
2381089-83-2
|
NOP2Y096GV
|
Retatrutide
| null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.